| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 北五加皮苷M; Periplocoside M | CFN93161 | 116782-73-1 | C34H52O9 = 604.78 | 5mg | QQ客服：2056216494 |
| 北五加皮苷N; Periplocoside N | CFN93240 | 39946-41-3 | C27H44O6 = 464.64 | 5mg | QQ客服：215959384 |
| 华蟾毒精醇; Cinobufaginol | CFN91051 | 6691-83-4 | C26H34O7 = 458.55 | 5mg | QQ客服：1413575084 |
| 7beta-羟基蟾毒灵; 7beta-Hydroxybufalin | CFN94058 | 20143-97-9 | C24H34O5 = 402.53 | 5mg | QQ客服：3257982914 |
| 二氢醉茄素A; Dihydrowithaferin A | CFN91055 | 5589-41-3 | C28H40O6 = 472.6 | 5mg | QQ客服：215959384 |
| 脱氧延龄草A; Deoxytrillenoside A | CFN93324 | 77658-50-5 | C47H70O23 = 1003.04 | 5mg | QQ客服：3257982914 |
| Parispseudoside C; Parispseudoside C | CFN93325 | 1206707-59-6 | C57H90O26 = 1191.31 | 5mg | QQ客服：2056216494 |
| 延龄草A; Trillenoside A | CFN93326 | 58809-09-9 | C47H70O24 = 1019.05 | 5mg | QQ客服：2056216494 |
| Trillikamtoside Q; Trillikamtoside Q | CFN93327 | 2098642-70-5 | C49H72O25 = 1061.08 | 5mg | QQ客服：2159513211 |
| Trillikamtoside R; Trillikamtoside R | CFN93328 | 2098642-71-6 | C49H72O25 = 1061.08 | 5mg | QQ客服：2056216494 |
| Trikamsteroside D; Trikamsteroside D | CFN93329 | 952579-36-1 | C48H74O24 = 1035.09 | 5mg | QQ客服：1457312923 |
| Trikamsteroside C; Trikamsteroside C | CFN93330 | 952579-35-0 | C47H70O24 = 1019.04 | 5mg | QQ客服：1457312923 |
| Trikamsteroside E; Trikamsteroside E | CFN93331 | 952579-37-2 | C48H76O23 = 1021.10 | 5mg | QQ客服：215959384 |
| 旌节花甾酮 D; Stachysterone D | CFN93334 | 26361-67-1 | C27H42O6 = 462.62 | 5mg | QQ客服：3257982914 |
| 2-乙酰基-20-羟基蜕皮甾酮; 2-O-Acetyl-20-hydroxyecdysone | CFN93337 | 19536-25-5 | C29H46O8 = 522.67 | 5mg | QQ客服：3257982914 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)